Literature DB >> 25540320

The spectrum of acute encephalitis: causes, management, and predictors of outcome.

Tarun D Singh1, Jennifer E Fugate1, Alejandro A Rabinstein2.   

Abstract

OBJECTIVE: To describe and analyze etiologies, clinical presentations, therapeutic management, and outcomes of patients with acute encephalitis and identify outcome predictors.
METHODS: We conducted a retrospective review of patients diagnosed with acute encephalitis at Mayo Clinic Rochester between January 2000 and December 2012. On the basis of the final diagnosis, the patients were categorized into 3 groups: viral encephalitis, autoimmune encephalitis, and encephalitis of unknown/other etiology. Multivariate logistic regression analysis was used to analyze factors associated with good (modified Rankin Scale scores of 0-2) or poor (scores of 3-6) outcome at hospital discharge.
RESULTS: We identified 198 patients (100 [50.5%] men and 98 [49.5%] women) with a median age of 58 years (range 41.8-69). Etiologies included viral infection (n = 95, 48%), autoimmune (n = 44, 22%), and unknown/others (n = 59, 30%). Good outcome at discharge was achieved by 48 patients (50.5%) with viral encephalitis, 17 (40.5%) with autoimmune encephalitis, and 32 (54.2%) with unknown/other etiologies. Mortality rates were 8%, 12%, and 5% in each of the 3 categories, respectively. On multivariate regression analysis, the factors that were associated with poor outcome were age 65 years or older (p = 0.0307), immunocompromised state (p = 0.0153), coma (p = 0.0062), mechanical ventilation (p = 0.0124), and acute thrombocytopenia (p = 0.0329). CSF polymorphonuclear cell count was also strongly associated with poor outcome in viral encephalitis (p = 0.0027).
CONCLUSIONS: Advanced age, immunocompromised state, coma, mechanical ventilation, and acute thrombocytopenia portend a worse prognosis in acute encephalitis. In contrast, the etiology of encephalitis, development of seizures or focal neurologic deficit, and MRI findings were not associated with clinical outcomes.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25540320     DOI: 10.1212/WNL.0000000000001190

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Alexander Filatenkov; Timothy E Richardson; Elena Daoud; Sarah F Johnson-Welch; Denise M Ramirez; Jose Torrealba; Benjamin Greenberg; Nancy L Monson; Veena Rajaram
Journal:  Neuroreport       Date:  2017-09-27       Impact factor: 1.837

2.  Fecal microbiota transplantation from patients with autoimmune encephalitis modulates Th17 response and relevant behaviors in mice.

Authors:  Hao Chen; Zhaoyu Chen; Liping Shen; Xiuhua Wu; Xueying Ma; Dengna Lin; Man Zhang; Xiaomeng Ma; Yingying Liu; Zhanhang Wang; Yuefeng Zhang; Zuying Kuang; Zhiwei Lu; Xuefei Li; Lili Ma; Xiuli Lin; Lei Si; Xiaohong Chen
Journal:  Cell Death Discov       Date:  2020-08-11

3.  Infectious encephalitis: utility of a rational approach to aetiological diagnosis in daily clinical practice.

Authors:  C López-Sánchez; E Sulleiro; C Bocanegra; S Romero; G Codina; I Sanz; J Esperalba; J Serra; C Pigrau; J Burgos; B Almirante; V Falcó
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

4.  New-onset refractory status epilepticus: Etiology, clinical features, and outcome.

Authors:  Nicolas Gaspard; Brandon P Foreman; Vincent Alvarez; Christian Cabrera Kang; John C Probasco; Amy C Jongeling; Emma Meyers; Alyssa Espinera; Kevin F Haas; Sarah E Schmitt; Elizabeth E Gerard; Teneille Gofton; Peter W Kaplan; Jong W Lee; Benjamin Legros; Jerzy P Szaflarski; Brandon M Westover; Suzette M LaRoche; Lawrence J Hirsch
Journal:  Neurology       Date:  2015-08-21       Impact factor: 9.910

5.  Outcomes of RIP Kinase Signaling During Neuroinvasive Viral Infection.

Authors:  Brian P Daniels; Andrew Oberst
Journal:  Curr Top Microbiol Immunol       Date:  2020-04-07       Impact factor: 4.291

Review 6.  [Intensive care aspects of autoimmune encephalitis].

Authors:  A Günther; J Schubert; O W Witte; D Brämer
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-27       Impact factor: 0.840

7.  Burden of herpes simplex virus encephalitis in the United States.

Authors:  S Modi; Abhimanyu Mahajan; D Dharaiya; P Varelas; P Mitsias
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

8.  Retrospective Review of Clinical Utility of Shotgun Metagenomic Sequencing Testing of Cerebrospinal Fluid from a U.S. Tertiary Care Medical Center.

Authors:  Kyle G Rodino; Michel Toledano; Andrew P Norgan; Bobbi S Pritt; Matthew J Binnicker; Joseph D Yao; Allen J Aksamit; Robin Patel
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

9.  Predictors of outcome in HSV encephalitis.

Authors:  Tarun D Singh; Jennifer E Fugate; Sara Hocker; Eelco F M Wijdicks; Allen J Aksamit; Alejandro A Rabinstein
Journal:  J Neurol       Date:  2015-11-14       Impact factor: 4.849

10.  Electrographic Seizures in Patients with Acute Encephalitis.

Authors:  Tanuwong Viarasilpa; Nicha Panyavachiraporn; Gamaleldin Osman; Christopher Parres; Panayiotis Varelas; Meredith Van Harn; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.